Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone and Suboxone for Injecting Drug Users in Vietnam
NCT05368675Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2013
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, open-label, single-arm trial of methadone and buprenorphine + naloxone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Primary endpoints: Retention in treatment program at 12 months, Adherence in treatment program at 12 months and 1 more. Started Dec 2013; status: completed.
02
Drugs
methadonebuprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05368675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368675.